| 1000 blog results |
|
-
Contributor: Yali Friedman
Contributor: 05/18/2013 12:00:00 AM EDT
Singapore’s biomedical science sector development strategy: Is it sustainable? Copyright © thinkBiotech This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology Singapore's biomedical science sector development strategy: Is it sustainable? Go to paperABSTRACT: This paper outlines the strategic efforts undertaken by. read more
-
Contributor: Yali Friedman
Contributor: 05/15/2013 12:00:00 AM EDT
Introducing BiologicPatentWatch: Biotechnology Industry Competitive Intelligence Copyright © thinkBiotech After months of development, BiologicPatentWatch.com is live. Building on the framework of DrugPatentWatch, BiologicPatentWatch provides comprehensive details on FDA approved biologic drugs, developers and patents. read more
-
Contributor: Yali Friedman
Contributor: 05/14/2013 12:00:00 AM EDT
Drug Patent Expirations for May 14 2013 Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations Advertise here This newsletter is a free service of DrugPatentWatch DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents Drug Patent Expirations for May 14 2013 Tradename Applicant Generic Name Patent Expiration DEPOCYT Pacira Pharms Inc cytarabine May 14, 2013 ZOMIG Astrazeneca zolmitriptan read more
-
Contributor: Yali Friedman
Contributor: 05/14/2013 12:00:00 AM EDT
Bowman v. Monsanto Supreme Court Decision for GM Seeds Patents, Licensing Copyright © thinkBiotech This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. read more
-
Contributor: Yali Friedman
Contributor: 05/13/2013 12:00:00 AM EDT
Drug Patent Expirations for May 13 2013 Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations Advertise here This newsletter is a free service of DrugPatentWatch DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents Drug Patent Expirations for May 13 2013 Tradename Applicant Generic Name Patent Expiration ZAVESCA Actelion Pharms Ltd miglustat May 13, 2013 *Drugs may be covered by read more
-
Contributor: Yali Friedman
Contributor: 05/13/2013 12:00:00 AM EDT
Drug Patent Expirations in May 2013 Copyright © thinkBiotech Drug Patent Expirations for May 2013 Tradename Applicant Generic Name Patent Number Patent Expiration HUMALOG PEN Lilly insulin lispro recombinant 5,514,646 May 7, 2013 GEMZAR Lilly gemcitabine hydrochloride 5,464,826*PED May 7, 2013 HUMALOG MIX 50. read more
-
Contributor: Yali Friedman
Contributor: 05/10/2013 12:00:00 AM EDT
Introducing BiologicPatentWatch: Biotechnology Industry Competitive Intelligence Copyright © thinkBiotech BiologicPatentWatch concentrates deep knowledge on biologic drugs from more than 60 biotechnology companies, including more than 2,800 active and expired US patents and 41,000 patents spanning 91 international patent offices. read more
-
Contributor: Yali Friedman
Contributor: 05/07/2013 12:00:00 AM EDT
Drug Patent Expirations for May 7 2013 Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations Advertise here This newsletter is a free service of DrugPatentWatch DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents Drug Patent Expirations for May 7 2013 Tradename Applicant Generic Name Patent Expiration GEMZAR Lilly gemcitabine hydrochloride May 7, 2013 HUMALOG Lilly insulin lispro read more
-
Contributor: Yali Friedman
Contributor: 05/07/2013 12:00:00 AM EDT
Marketspace: Leading biotechnology players, 2002–08: Key products, indications and technologies Copyright © thinkBiotech This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology Marketspace: Leading biotechnology players, 2002–08: Key products, indications and technologies Go to paper ABSTRACT: For the full year 2002, the top ten biotechnology houses generated combined revenues (= royalties/licensing income + ethical or product sales; product sales includes both diagnostic and prescription drugs) of US$15. read more
-
Contributor: Yali Friedman
Contributor: 05/01/2013 12:00:00 AM EDT
Drug Patent Expirations for Apr 30 2013 Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations Advertise here This newsletter is a free service of DrugPatentWatch DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents Drug Patent Expirations for April 30 2013 Tradename Applicant Generic Name Patent Expiration ALVESCO Takeda Gmbh ciclesonide Apr 30, 2013 CEDAX Pernix Therap read more
| 1000 blog results |
|
|
|
|
|
-
Artwork Matters:
Making it Happen: Change Management Issues in Artwork Improvement Programmes: My previous articles have discussed the processes and capabilities required to develop a performing artwork and labelling ability in your organisation. read more
Packaging and Labelling | change management | Artwork Improvement Programmes
-
Drug Delivery:
The Search for New and Innovative Excipients – Possible Applications of Semi Fluorinated Alkanes: read more
SFA | drug delivery | René Holm
-
Intelligent Drug Development Applied to Drug Transporters: Drug development is growing up.... read more
clinically relevant drug transporters | NCE | drug development
-
Top 10 Statistics From Pharma IQ's Clinical Trial Supply Survey: The latest results... read more
clinical trial supply usa | BRIC | emerging markets
|
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >> Learn how to sponsor a webinar with us? Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more. Sign Up Today! |
| Pharma IQ, a division of IQPC 2013 All rights reserved. Use of this site constitutes acceptance of our User Agreement and Privacy Policy. Careers With IQPC | Contact Us | Unsubscribe to Bizo | About Us | Cookie Policy |
|
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!